Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cloaked Delivery System Designed to Kill Tumors from Within

By LabMedica International staff writers
Posted on 01 Nov 2010
Researchers have demonstrated that they can deliver a dormant toxin into a specific site such as a tumor for anticancer therapy, then chemically trigger the toxin to de-cloak and attack from within. More...
It holds promise as an advanced synthetic, therapeutic drug delivery system for living cells.

An article describing the new host-guest chemistry application, led by University of Massachusetts Amherst (MA, USA) chemist Dr. Vincent Rotello and colleagues, with Dr. Lyle Isaacs at the University of Maryland (College Park, USA), was published in the October 2010 issue of the journal Nature Chemistry. As Dr. Rotello explained, "Supramolecular chemistry focuses on understanding what forces make molecules stick together, and using these forces to control the assembly of functional systems. This assembly process is much like Lego blocks, where bumps and dimples interact to hold biomolecules like DNA and proteins together.”

Specifically, Dr. Rotello and colleagues covered specialized gold nanoparticles with ligand or binding molecules (the bump) that made the particles toxic. These ligands, however, also can strongly bind to a hollow, bowl-shaped molecule (the dimple to which the bump sticks) called a cucurbituril that can make the particle nontoxic. When the gold nanoparticles are introduced into living cells, they lie dormant. The researchers then use another molecule that binds strongly to the dimple-shaped cucurbiturils, pulling them away from the gold nanoparticle so it becomes uncloaked and toxic.

"This triggered toxicity opens up new directions for controlled chemotherapeutics, where toxicity can be tuned by and directed through choice and amount of added activator,” Dr. Rotello stated. "They would be capable of achieving higher levels of site-specific activity with reduced collateral damage to surrounding healthy cells.”

The researchers are now examining this strategy in cells and will be moving to in vivo systems soon to explore comprehensively issues related to real-world application of the system.

Related Links:
University of Massachusetts Amherst
University of Maryland



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
POC Immunoassay Analyzer
Procise DX
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) is a rare malignancy that often progresses silently, frequently going undetected until it reaches advanced stages. By the time it spreads to bone, it can produce unusual... Read more

Molecular Diagnostics

view channel
Image: In the Fetal Extracellular Vesicle Monitoring of Oxygenation (FEMOx) project several of the Wyss Institute’s Technology Platforms and faculty labs join forces. Leveraging and integrating multiple of the Wyss Institute’s technological innovations and advanced analytical capabilities they aim develop a test that can rapidly and accurately detect fetal oxygen deprivation by detecting specific miRNA signatures in extracellular vesicles (EVs) that circulate in maternal blood. (Iimage Credit: Wyss Institute at Harvard University)

Project to Develop Maternal Blood Test for Rapid Fetal Oxygen Deprivation Detection

Intrapartum fetal hypoxia remains difficult to assess with existing monitoring, leaving clinicians to make time-critical decisions with incomplete data. Limited detection and interpretation can contribute... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.